Brady Martz Wealth Solutions LLC Acquires Shares of 1,799 UnitedHealth Group Incorporated (NYSE:UNH)

Brady Martz Wealth Solutions LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 1,799 shares of the healthcare conglomerate's stock, valued at approximately $978,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Delta Financial Group Inc. increased its stake in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate's stock valued at $965,000 after acquiring an additional 17 shares during the period. First PREMIER Bank boosted its stake in UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate's stock valued at $160,000 after buying an additional 18 shares in the last quarter. Genesee Capital Advisors LLC lifted its holdings in shares of UnitedHealth Group by 1.9% during the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate's stock valued at $579,000 after acquiring an additional 18 shares during the period. Jmac Enterprises LLC increased its holdings in UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate's stock valued at $481,000 after purchasing an additional 18 shares in the last quarter. Finally, Matrix Private Capital Group LLC boosted its position in UnitedHealth Group by 3.6% in the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate's stock valued at $276,000 after buying an additional 19 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH stock traded down $0.56 during mid-day trading on Monday, reaching $510.03. The stock had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The firm has a market capitalization of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The stock's 50-day moving average price is $549.37 and its two-hundred day moving average price is $563.70. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group's dividend payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on UNH shares. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday. Morgan Stanley decreased their price objective on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. StockNews.com lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Wednesday, January 15th. Finally, HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.